insights+Analyses Published

We're attuned to (often ahead of) the key issues facing the market. It's about arming investors, consumers, and businesses with the information they need to make sound decisions.
Articles filtered by:
ThinkstockPhotos-71262728-1
INSIGHTS & ANALYSES

FDA Risk-Evaluation Guidance Unlikely To Help Generics

Gregory Asciolla and Matthew Perez discuss the U.S. FDA’s guidances concerning risk evaluation and mitigation strategies and the likely minimal ...

Tuesday, June 12, 2018

by Gregory Asciolla, Matthew Perez
1